174 related articles for article (PubMed ID: 12680240)
1. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.
Nazeyrollas P; Frances C; Prevost A; Costa B; Lorenzato M; Kantelip JP; Elaerts J; Millart H
Anticancer Res; 2003; 23(1A):405-9. PubMed ID: 12680240
[TBL] [Abstract][Full Text] [Related]
2. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats.
Jahnukainen K; Jahnukainen T; Salmi TT; Svechnikov K; Eksborg S; Söder O
Cancer Res; 2001 Sep; 61(17):6423-7. PubMed ID: 11522636
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin induces apoptosis in germ line stem cells in the immature rat testis and amifostine cannot protect against this cytotoxicity.
Hou M; Chrysis D; Nurmio M; Parvinen M; Eksborg S; Söder O; Jahnukainen K
Cancer Res; 2005 Nov; 65(21):9999-10005. PubMed ID: 16267025
[TBL] [Abstract][Full Text] [Related]
4. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity.
Nazeyrollas P; Prévost A; Baccard N; Manot L; Devillier P; Millart H
Cancer Chemother Pharmacol; 1999; 43(3):227-32. PubMed ID: 9923553
[TBL] [Abstract][Full Text] [Related]
5. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Herman EH; Zhang J; Chadwick DP; Ferrans VJ
Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
[TBL] [Abstract][Full Text] [Related]
7. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction.
Chicco AJ; Schneider CM; Hayward R
J Cardiovasc Pharmacol; 2006 Feb; 47(2):182-9. PubMed ID: 16495754
[TBL] [Abstract][Full Text] [Related]
8. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats.
Bennink RJ; van den Hoff MJ; van Hemert FJ; de Bruin KM; Spijkerboer AL; Vanderheyden JL; Steinmetz N; van Eck-Smit BL
J Nucl Med; 2004 May; 45(5):842-8. PubMed ID: 15136635
[TBL] [Abstract][Full Text] [Related]
9. Acute exercise protects against doxorubicin cardiotoxicity.
Wonders KY; Hydock DS; Schneider CM; Hayward R
Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
[TBL] [Abstract][Full Text] [Related]
10. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.
Anjos Ferreira AL; Russell RM; Rocha N; Placido Ladeira MS; Favero Salvadori DM; Oliveira Nascimento MC; Matsui M; Carvalho FA; Tang G; Matsubara LS; Matsubara BB
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):16-24. PubMed ID: 17577311
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
12. General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles.
Leo E; Arletti R; Forni F; Cameroni R
Farmaco; 1997; 52(6-7):385-8. PubMed ID: 9372590
[TBL] [Abstract][Full Text] [Related]
13. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
[TBL] [Abstract][Full Text] [Related]
14. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
Hydock DS; Lien CY; Schneider CM; Hayward R
Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.
Platel D; Bonoron-Adèle S; Dix RK; Robert J
Br J Cancer; 1999 Sep; 81(1):24-7. PubMed ID: 10487608
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat.
Chugun A; Temma K; Oyamada T; Suzuki N; Kamiya Y; Hara Y; Sasaki T; Kondo H; Akera T
Can J Physiol Pharmacol; 2000 Apr; 78(4):329-38. PubMed ID: 10772060
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats.
Mostafa AM; Nagi MN; Al Rikabi AC; Al-Shabanah OA; El-Kashef HA
Res Commun Mol Pathol Pharmacol; 1999; 106(3):193-202. PubMed ID: 11485049
[TBL] [Abstract][Full Text] [Related]
18. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein.
Andreadou I; Papaefthimiou M; Zira A; Constantinou M; Sigala F; Skaltsounis AL; Tsantili-Kakoulidou A; Iliodromitis EK; Kremastinos DT; Mikros E
NMR Biomed; 2009 Jul; 22(6):585-92. PubMed ID: 19308947
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats.
Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P
J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805
[TBL] [Abstract][Full Text] [Related]
20. [The prevention of the myocardial toxicity of doxorubicin with superoxide dismutase].
Villani F; Galimberti M; Favalli L; Rozza A; Lanza E; Poggi P
G Ital Cardiol; 1991 Jun; 21(6):633-41. PubMed ID: 1743445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
